AT
AEHR TEST SYSTEMS (AEHR)·Q2 2025 Earnings Summary
Executive Summary
- Q2 FY25 revenue was $13.5M, down 37% year-over-year and modestly up quarter-over-quarter; GAAP EPS was $(0.03) and non-GAAP EPS was $0.02, reflecting soft SiC demand and timing delays of expected system orders into Q3 .
- Results missed S&P Global consensus: revenue $15.0M* vs actual $13.5M and EPS $0.03* vs non-GAAP $0.02; bookings were $9.2M and effective backlog rose to $26.6M, mitigating near-term visibility concerns .
- Management reaffirmed FY25 guidance for at least $70M revenue and ≥10% non-GAAP PBT margin, citing acceleration in AI processor burn-in (first wafer-level AI customer and volume Sonoma packaged burn-in orders) and first GaN production order .
- Stock-relevant catalysts: shipment timing from prebuilt AI/GaN systems, multi-market diversification (AI, GaN, HDD, silicon photonics), and China IP litigation risks impacting SiC bookings cadence .
What Went Well and What Went Wrong
What Went Well
- First wafer-level AI processor customer selected FOX-XP for production burn-in; initial orders for multiple systems and WaferPaks secured, a “technological and commercial breakthrough” expanding TAM in AI .
- First volume production Sonoma ultra-high-power packaged burn-in orders from a hyperscaler; shipments commenced to an Asian OSAT, positioning for AI packaged burn-in growth .
- First GaN production order using FOX-XP, broadening beyond SiC with >40% CAGR market outlook and >10% power semi mix by 2028, per Yole/Frost & Sullivan references; management emphasized multi-market diversification .
What Went Wrong
- YoY revenue fell to $13.5M from $21.4M; non-GAAP gross margin contracted to 45.3% vs 51.6% last year, driven by lower revenue and mix, while non-GAAP OpEx rose on Incal and legal costs .
- Timing: prebuilt AI/GaN systems missed quarter-end due to PO finalization after Q2, depressing the quarter; management flagged volatility from high ASP systems and does not provide quarterly guidance .
- China risks: IP suit filed against a local supplier; trade and competitive dynamics heighten risk to contemplated SiC orders and revenue from Chinese customers in FY25 .
Financial Results
Consolidated P&L and Margins (oldest → newest)
Product vs Services, Recurring Mix (oldest → newest)
KPIs and Balance Sheet (oldest → newest)
vs. S&P Global Consensus (Q2 FY25)
Values marked with * retrieved from S&P Global.
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “Securing our first AI processor customer for wafer level burn-in… represents a technological and commercial breakthrough… significantly expanding the market potential for our FOX-XP wafer level test and burn-in systems.”
- “During the quarter, we secured our first production AI processor customer for package part burn-in… initial volume production orders for multiple Sonoma ultra-high-power systems… shipments have already commenced to their contract manufacturer in Asia.”
- “We announced another exciting milestone with our first gallium nitride (GaN) semiconductor production order… GaN… is projected to surpass $2 billion in annual device sales by 2029.”
- “Given the nature of our business… quarterly revenue can experience significant variability… both [AI and GaN] customers requested prebuilt systems… purchase orders were not finalized until after the quarter ended.”
- “We filed a lawsuit in China against a local supplier for intellectual property infringement… heighten the risk associated with bookings and revenue from Chinese customers.”
Q&A Highlights
- Shipping timing: Systems “on the shipping dock” with POs finalized after quarter end; Q2 would have been “significantly higher” absent end-of-quarter concessions, with orders moving into Q3 .
- Mix and margins: Non-GAAP gross margin compressed; WaferPak has best margins, Aehr systems next, Incal systems lower; operational efficiencies expected as Incal manufacturing consolidates into Fremont .
- Near-term drivers: Expect more AI production (wafer-level and packaged) and SiC orders with new customers; HDD looks attractive longer-term but near-term AI and SiC are bigger .
- China/competition: Despite IP concerns, AEHR cites strong competitive advantage vs local tools; still acknowledges trade/regulatory uncertainty could delay a several-million-dollar system sale .
- Memory pathways: Technical drivers in NAND/DRAM/HBM point toward higher test power and reliability needs pre-advanced packaging, aligning with AEHR capabilities .
Estimates Context
- Q2 FY25 miss vs S&P Global consensus: revenue $15.0M* vs actual $13.5M and EPS $0.03* vs non-GAAP $0.02; backdrop included softness in SiC and PO timing .
- Q1 FY25 beat vs S&P Global on both top and bottom lines: revenue $12.2M* vs actual $13.1M and EPS $0.015* vs non-GAAP $0.07 .
- FY25 consensus $60.6M* vs AEHR reiterated at ≥$70M, implying upward estimate risk if execution on AI/GaN/HDD ramps and China SiC bookings materialize .
Values marked with * retrieved from S&P Global.
Key Takeaways for Investors
- Diversification is real-time: AI wafer-level and packaged burn-in are moving from evaluation to initial production, adding a new growth vector and reducing reliance on SiC EV cycles .
- Near-term revenue cadence depends on shipment timing of high-ASP systems; effective backlog of $26.6M supports sequential recovery into Q3/Q4 .
- Margin trajectory hinges on mix: WaferPak drives higher margins; increased Incal system mix weighs near-term but should improve with consolidation and scale .
- China exposure introduces headline and execution risk to SiC orders (IP litigation, trade), but management cites product superiority and longstanding presence in region .
- HDD and silicon photonics represent credible incremental TAMs with production ramps forecast across the next few quarters and fiscal year .
- Cash cushion ($35.2M) and no debt provide flexibility; new $100M shelf in place for opportunistic financing if required .
- FY25 guide maintained despite Q2 softness; execution on AI/GaN/HDD offsets SiC challenges—monitor orders, backlog conversion, and gross margin mix each quarter .